A Study to Characterize the Elimination of Guselkumab Glycoform Variants in Healthy Participants

NCT02570373 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Guselkumab

Sponsor

Janssen Research & Development, LLC